Apimeds Pharmaceuticals US, Inc. (APUS) stock
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.95−0.09 (-4.41%)
Close on Nov 17, 2026Market cap $2.94MP/E –Yield –
Apimeds Pharmaceuticals US market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Apimeds Pharmaceuticals US's market cap was $3.56M on Nov 11, 2026, against $36.47M a year earlier.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.56M | -82.7% |
| 2025 | Dec 31, 2025 | $20.62M | – |
See a number that looks wrong?